SCD1-driven lipid metabolic reprogramming confers resistance to HER2-targeted therapies in breast cancer

First Author / 第一作者

MENG-XIA SU

Institution / 單位

Division of Breast Surgery, China Medical University Hospital

Audio / 音訊檔

Author Group / 作者群

Thanh Kieu Huynh, Ph.D. 2,4, Shih-Ting Huang, M.S.2,4、Wei-Chien Huang, Ph.D.2,4, Liang-Chih Liu, Ph.D. 1,3

Author Group Institution/ 作者群單位

1. Division of Breast Surgery, China Medical University Hospital 2. Center for Molecular Medicine, China Medical University Hospital 3. School of Medicine, College of Medicine, China Medical University 4. Graduate Institute of Biomedical Science, China Medical University

Category / 主題分類

Basic Research

Keyword / 關鍵字

Stearoyl-CoA desaturase 1, HER2-positive breast cancer, lapatinib

Back to list